Cargando…

Structural Basis for the Inhibition of a Phospholipase A(2)-Like Toxin by Caffeic and Aristolochic Acids

One of the main challenges in toxicology today is to develop therapeutic alternatives for the treatment of snake venom injuries that are not efficiently neutralized by conventional serum therapy. Venom phospholipases A(2) (PLA(2)s) and PLA(2)-like proteins play a fundamental role in skeletal muscle...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Carlos A. H., Cardoso, Fábio Florença, Cavalcante, Walter G. L., Soares, Andreimar M., Dal-Pai, Maeli, Gallacci, Marcia, Fontes, Marcos R. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508052/
https://www.ncbi.nlm.nih.gov/pubmed/26192963
http://dx.doi.org/10.1371/journal.pone.0133370
Descripción
Sumario:One of the main challenges in toxicology today is to develop therapeutic alternatives for the treatment of snake venom injuries that are not efficiently neutralized by conventional serum therapy. Venom phospholipases A(2) (PLA(2)s) and PLA(2)-like proteins play a fundamental role in skeletal muscle necrosis, which can result in permanent sequelae and disability. This leads to economic and social problems, especially in developing countries. In this work, we performed structural and functional studies with Piratoxin-I, a Lys49-PLA(2) from Bothropspirajai venom, complexed with two compounds present in several plants used in folk medicine against snakebites. These ligands partially neutralized the myotoxic activity of PrTX-I towards binding on the two independent sites of interaction between Lys49-PLA(2) and muscle membrane. Our results corroborate the previously proposed mechanism of action of PLA(2)s-like and provide insights for the design of structure-based inhibitors that could prevent the permanent injuries caused by these proteins in snakebite victims.